Invention Grant
- Patent Title: Methods of treatment using anti-erbb antibody-maytansinoid conjugates
-
Application No.: US11949351Application Date: 2007-12-03
-
Publication No.: US08093358B2Publication Date: 2012-01-10
- Inventor: Walter Blättler , Ravi V. J. Chari
- Applicant: Walter Blättler , Ravi V. J. Chari
- Applicant Address: US MA Waltham
- Assignee: Immunogen, Inc.
- Current Assignee: Immunogen, Inc.
- Current Assignee Address: US MA Waltham
- Agency: Sughrue Mion, PLLC
- Main IPC: C07K16/00
- IPC: C07K16/00

Abstract:
The application concerns methods of treatment using anti-ErbB receptor antibody-maytansinoid conjugates, and articles of manufacture suitable for use in such methods. In particular, the invention concerns ErbB receptor-directed cancer therapies, using anri-ErbB receptor antibody-maytansinoid conjugates.
Public/Granted literature
- US08337856B2 Methods of treatment using anti-ERBB antibody-maytansinoid conjugates Public/Granted day:2012-12-25
Information query